Condition: Colorectal Cancer Liver Metastases (CRLM) · Small Future Liver Remnant (FLR) · Sponsor: Maastricht University
In the randomized controlled DRAGON 2 trial study subjects will be randomized between two arms, PVE alone (control group) and PVE/HVE (interventional group).
This description comes directly from the study's public registry record.
Sinéad James, MD, PhD-candidate · +31 638463945 · sinead.james@mumc.nl
Jens Smits · +31640725518 · jens.smits@mumc.nl
Always discuss trial participation with your own doctor first.
| Yale New Haven Hospital | New Haven, Connecticut, United States | Recruiting |
| Monash Medical Centre | Clayton, Victoria, Australia | Recruiting |
| Social Medical Center, South | Vienna, State of Vienna, Austria | Not Yet Recruiting |
| Hôpital Erasme | Brussels, Brussels Capital, Belgium | Recruiting |
| CHU de Liège | Liège, Liège, Belgium | Recruiting |
| CHU-UCL Namur site Godinne | Yvoir, Namen, Belgium | Recruiting |
| UZ Gent | Ghent, Oost-Vlaanderen, Belgium | Recruiting |
| Vancouver Coastal Health | Vancouver, British Columbia, Canada | Recruiting |
| Juravinski Hospital and Cancer Centre | Hamilton, Ontario, Canada | Recruiting |
| The Ottawa Hospital | Ottawa, Ontario, Canada | Recruiting |
| Sunnybrook Hospital | Toronto, Ontario, Canada | Recruiting |
| McGill University Health Center | Montreal, Canada | Not Yet Recruiting |
+ 12 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05428735